Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rett syndrome
Biotech
Astellas turns down option to license Taysha gene therapy—again
The biotech plans to advance the gene therapy into late-stage development, with the launch of a pivotal trial slated for this quarter.
Gabrielle Masson
Oct 17, 2025 10:50am
Neurogene details death in Rett syndrome gene therapy trial
May 16, 2025 3:00pm
Patient put in critical condition by Neurogene gene therapy dies
Nov 22, 2024 3:57am
Neurogene acts as gene therapy puts person in critical condition
Nov 18, 2024 8:33am
Acadia makes $100M profit from $150M pediatric voucher sale
Nov 6, 2024 9:36am
A brain parasite has been turned into drug delivery system
Jul 29, 2024 2:55pm